Report Code: PHP09422. October, 2009. Toronto, ON
A Health Research Roadmap: Creating Innovative Research for Better Health and Healthcare
Alain Beaudet, MD., Ph.D.
Canadian Institutes of Health Research
National Initiatives and Innovation in REB Review in Canada
Ron Heslegrave Ph.D.
Chair, Research Ethics Board
University Health Network
Ontario Cancer Research Ethics Board
Attracting and Retaining Clinical Trials in Canada
President and Co-founder
Trial Management Group (TMG)
Marie-Claude Gauthier, B.Sc.
Director, Clinical Research
Pfizer Canada Inc.
Dr. Catriona McMahon, BSc., MBChB, FRCA (UK), MFPM (UK)
Vice President, Medical Affairs
AstraZeneca Canada Inc.
Unit Director, Regional Clinical Operations
Bristol-Myers Squibb Canada
Independent Ethics Review: Challenges and Opportunities
Institutional Review Board Services
Finding A Balance Between Innovation and Participant Protection
Completing the Drug Development Circle: Post-Marketing/Phase IV and Observational Clinical Trials
Dr. John S. Sampalis
Associate Professor of Surgery, Epidemiology & Biostatistics, McGill University, University of Montreal & Laval University; President
JSS Medical Research Inc.
Montreal Roundtable Summary: How Sponsors, Institutions/Pls and CROs Can Smooth Out and Speed Up the Negotiation of Clinical Trial Contracts in Canada
Marie-Luce Fortier, LL.L., LL.B.
Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)
Alaine C. Grand
AstraZeneca Canada Inc.
Michelle Moldofsky, LLB, LLM
Policy & Legal Advisory, Office of Research Administration
St. Michael’s Hospital
Maria Rossin, BA, LLB, JD
The Samuel Lunenfeld Research Institute
Clinical Trials Competitiveness
Vice President, Policy, Research, Regulatory & Scientific Affairs
Canada’s Research-Based Pharmaceutical Companies (Rx&D)
Privacy Issues in the Pharmaceutical Context: Legal, Ethical & IT Perspective
Khaled El Emam
Associate Professor, Canada Research Chair in Electronic Health Information
University of Ottawa
Chief GE3 LS Officer
Motivating Investigators in Specialized Clinical Research
Pierre Gervais, B.Pharm., MSc
Director, Business Development, Q&T Research Outaouais; Ex-president, Quebec Association of Clinical Research (AQRC); President
Q&T Research – Sherbrooke
Biotech and Big Pharma: Strategic, Innovative Partnerships in R&D
Matthew J. Carlyle
Chief Financial Officer
Allon Therapeutics, Inc.
Regulatory Transparency: Issues that Can Impact Our Competitive Effectiveness in the Conduct of Multicentre International Clinical Trials
Anne Tomalin, BA, BSc, RAC
Canada: Your Location of Choice for Clinical Trials
Brad Millson, BSc., MBS
Investment Advisor, Life Science Practice
Foreign Affairs and International Trade Canada